Glucose-lowering therapy delayed for newly diagnosed T2DM patients
(HealthDay)—For adults newly diagnosed with type 2 diabetes mellitus (T2DM), delays to first-line therapy are longest for older patients, those who are Black or...
Sugar is a DRUG
Study finds time-restricted eating may reduce diabetes-related hypertension
Credit: CC0 Public Domain A new University of Kentucky College of Medicine study suggests that time-restricted eating may be able to help people with...
Revita DMR: New Diabetes Procedure Gets “Breakthrough” Designation
A variety of classes of medications are used to help people manage their diabetes, but the quest for alternative means of treating the condition...
Trial results show two medications most effective in lowering blood glucose levels in type 2 diabetes patients
Credit: CC0 Public Domain Two medications have proven to be most effective in keeping blood glucose levels within a target range while managing type...
Higher Glucose Levels Linked to Bone Fracture Risk
Having elevated blood glucose is linked to a higher risk for bone fractures in older adults with type 2 diabetes, according to new research...
Extra Attention Leads to Oral Health Improvements in Type 2
Reminding people with type 2 diabetes to take good care of their oral health led to perceived improvements in this area, according to a...
Ultra-Processed Foods in Children Linked to Extra Weight As Adults
Consuming ultra-processed foods at a young age is linked to sustained weight gain into adulthood, according to a new study published in the journal...
Antidiabetic drug causes double the weight loss of competitor
Credit: Unsplash/CC0 Public Domain Patients with Type 2 diabetes who were prescribed SGLT2 inhibitors lost more weight than patients who received GLP-1 receptor agonists,...
Efpeglenatide lowers risk for adverse CV events in T2DM
(HealthDay)—For patients with type 2 diabetes and a history of cardiovascular disease or current kidney disease, the risk for adverse cardiovascular events is lower...
Tirzepatide noninferior, superior to semaglutide for T2DM
(HealthDay)—The dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist, tirzepatide, is noninferior and superior to semaglutide for reducing glycated hemoglobin levels among patients...